What is the duration of action of verapamil sustained-release (SR) formulation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Duration of Action of Verapamil SR

Verapamil sustained-release (SR) formulations have an elimination half-life of 12-17 hours and provide effective therapeutic coverage for 24 hours with once-daily dosing. 1

Pharmacokinetic Profile

The extended-release formulation of verapamil demonstrates significantly prolonged pharmacokinetics compared to immediate-release:

  • Elimination half-life (ER): 12-17 hours 1
  • Immediate-release half-life: 2-7 hours (single dose) or 4.5-12 hours (chronic dosing) 2
  • Peak plasma concentration: Achieved at 5-7 hours after administration 2

Clinical Duration of Action

Sustained-release verapamil maintains blood pressure control throughout a 24-hour dosing interval when administered once daily. Multiple studies confirm:

  • 24-hour efficacy: A single 240 mg SR dose maintains significant blood pressure reduction for up to 20 hours, with some attenuation in the final 4 hours of the dosing interval 3
  • Consistent coverage: Both 24-hour ambulatory monitoring and clinical studies demonstrate maintained therapeutic effect throughout the day and night 4, 5
  • Once-daily dosing: The SR formulation at 240-480 mg daily provides adequate rate control in atrial fibrillation and blood pressure control in hypertension 1, 6

Important Clinical Considerations

Hepatic Impairment

In severe liver dysfunction, the elimination half-life extends dramatically to 14-16 hours, requiring dose reduction to approximately 30% of normal dosing 2. This substantially prolongs the duration of action and increases risk of toxicity.

Overdose Context

Monitor patients for at least 48 hours after overdose with SR formulations due to delayed pharmacodynamic consequences 2. The sustained-release mechanism can result in prolonged drug absorption and extended toxic effects.

Food Effects

Food significantly reduces bioavailability of SR verapamil (AUC decreases by approximately 43%) but produces a narrower peak-to-trough ratio, which may actually enhance the sustained effect 2.

Dosing Implications

The 12-17 hour half-life supports:

  • Once-daily administration for most indications (hypertension, rate control)
  • Maintenance doses: 180-480 mg daily for oral ER formulations 1, 6
  • Steady-state: Achieved after multiple doses, with accumulation expected due to nonlinear pharmacokinetics 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.